Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis

BACKGROUND: Major depressive disorder (MDD) is a debilitating and costly mental disorder. Although commercially available antidepressants have proliferated over the last 20 years, a substantial number of patients either do not respond adequately to these drugs or are unable to tolerate their adverse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Syst Rev
Autors principals: Liu, Yiyun, Zhou, Xinyu, Qin, Bin, Del Giovane, Cinzia, Zhang, Yuqing, Xie, Peng
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234739/
https://ncbi.nlm.nih.gov/pubmed/25373601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-133
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars